Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2025 Sep 5;81(Pt 10):912–915. doi: 10.1107/S2056989025003317

Crystal structure and Hirshfeld surface studies of 4-bromo-2-chloro­phenyl (2E)-3-[4-(pent­yloxy)phen­yl]prop-2-enoate

M Harish Kumar a, S Santhosh Kumar b, H C Devarajegowda a, H T Srinivasa c, B S Palakshamurthy b,*
Editor: F Di Salvod
PMCID: PMC12498039  PMID: 41059315

In the title compound, the aromatic rings are oriented at a dihedral angle of 83.30 (2)°. An intra­molecular C—H⋯O contact generates a five-membered S(5) ring motif. In the crystal, C—H⋯O hydrogen bonds link the mol­ecules through R12(6), R22(10), R22(14) hydrogen-bond motifs.

Keywords: crystal structure, 4-bromo-2-chloro­phen­yl, Hirshfeld surface

Abstract

The asymmetric unit of the compound C20H20BrClO3 contains one independent mol­ecule in which the aromatic rings are oriented at a dihedral angle of 83.30 (2)°. An intra­molecular C—H⋯O contact generates a five-membered S(5) ring motif. In the crystal, C—H⋯O hydrogen bonds link the mol­ecules through R12(6), R22(10), R22(14) hydrogen-bond motifs. The structure is consolidated by C—H⋯π inter­actions. A Hirshfeld surface analysis of the crystal structure indicates that the most important contributions for the crystal packing are from H⋯H (32.8%), C⋯H/H⋯C (28.1%), O⋯H/H⋯O (14.0%) Br⋯H/H⋯Br (12.5%) and Cl⋯H/H⋯Cl (10.6%) inter­actions.

1. Chemical context

4-Bromo-2-chloro­phenyl derivatives possess an inter­esting in vitro inhibitory activity on plasmodium falciparum bacteria and serve as the starting mol­ecule for structure-based design of novel inhibitors for anti-plasmodial and transmission-blocking agents (Vallone et al., 2018). These compounds are known to exhibit anti-malarial activity (Kos et al., 2022). Compounds having halogen atoms at the ortho and meta positions with respect to the bromine have also been found to exhibit anti-inflammatory activity (Hošek et al., 2019). This class of compounds are very important for the design of drugs for the treatment of diseases such as dengue and chikungunya and furthermore, the introduction of alkyl groups into these compounds will induce better penetration capacity at the cellular level. Compounds obtained by combining 4-bromo-2-chloro­phenyl and (alk­yloxy)phenyl-derived mol­ecules are well known for their anti­microbial activity (Radwan et al., 2014) and anti­tumor properties (Jung et al., 2019; Pieters et al., 1999). The role of alkyl groups in the various drug mol­ecules is to speed up the penetration of compounds into the cell i.e. into mitochondria. In this context, it is found that decyl­caffeic acid inhibits the growth of colorectal cancer cells (Lukáč et al., 2024) and alkyl groups in cinnamic acid-based mol­ecules encourage anti­tuberculosis activity (De et al., 2011). The alkyl group, which makes an amido links with various aromatic or heterocyclic rigid cores, will enhance the degree of inhibition activity of anti-inflammatory drugs (Matta et al., 2020). Keeping these properties in mind, we decided to synthesize and study the title compound, which has both a rigid core (4-bromo-2-chloro­phen­yl) and an alk­yloxy chain linked through the ester group and present the results herein.1.

2. Structural commentary

The title compound (Fig. 1) crystallizes in space group PInline graphic. The dihedral angle between the 4-bromo-2-chloro­phenyl aromatic ring (C1–C6) and the aromatic ring of the pent­yloxy phenyl fragment (C10–C15) is 83.30 (2)°. The torsion angles C1—O1—C7—C8 and C13—O3—C16—C17 are 175.98 (14) and −179.32 (14)°, respectively, which are anti-periplanar. The H8—C8=C9—H9 atoms exhibit an E-configuration with a torsion angle of 178° and the mol­ecule is non planar with an r.m.s. deviation of 0.065 Å. An intra­molecular hydrogen-bond inter­action generates an S(5) motif (Fig. 2b).

Figure 1.

Figure 1

The mol­ecular structure of the title compound, showing displacement ellipsoids drawn at the 50% probability level.

Figure 2.

Figure 2

The mol­ecular packing of the title compound. Dashed lines indicate the C—H⋯O hydrogen-bonding inter­actions. The Inline graphic(6), Inline graphic(10) (a) and Inline graphic(14) (b) synthons are indicated by dotted pale-green lines and the S(5) ring is shown in pink (b).

3. Supra­molecular features

In the crystal, C—H⋯O hydrogen bonds (Table 1, Fig. 2a) link the mol­ecules through Inline graphic(6), Inline graphic(10) and Inline graphic(14) cyclic hydrogen-bond motifs (Bernstein et al., 1995), forming inversion dimers. Together these inter­actions generate mol­ecular sheets parallel to (010). The inversion dimers are linked through weak C—H⋯Cl inter­actions (Table 1) as shown in Fig. 3. The packing is further consolidated by C—H⋯π inter­actions (Fig. 4, Table 1).

Table 1. Hydrogen-bond geometry (Å, °).

Cg1 and Cg2 are the centroids of the 4-bromo-2-chloro­phenyl (C1–C6) and phenyl (C10–C15) rings, respectively.

D—H⋯A D—H H⋯A DA D—H⋯A
C6—H6⋯Cl1i 0.93 2.93 3.613 (2) 131
C9—H9⋯O2 0.93 2.50 2.848 (2) 102
C9—H9⋯O2ii 0.93 2.46 3.291 (2) 149
C15—H15⋯O2ii 0.93 2.58 3.371 (2) 143
C11—H11⋯Cg1iii 0.93 2.76 3.5716 (18) 147
C16—H16BCg2iv 0.97 2.79 3.6687 (17) 151
C18—H18BCg2v 0.97 2.85 3.7194 (17) 150

Symmetry codes: (i) Inline graphic; (ii) Inline graphic; (iii) Inline graphic; (iv) Inline graphic; (v) Inline graphic.

Figure 3.

Figure 3

The mol­ecular packing of the title compound with weak C—H⋯Cl inter­actions indicated by magenta coloured dashed lines.

Figure 4.

Figure 4

The mol­ecular packing of the title compound. Dashed lines indicate the C—H⋯π inter­actions.

4. Hirshfeld surface analysis

Hirshfeld surface analysis (Hirshfeld, 1977; Spackman & Jayatilaka, 2009) was used to visualize and qu­antify inter­molecular inter­actions using Crystal Explorer (Spackman et al., 2021). The two-dimensional fingerprint plots (Fig. 5) qu­anti­fying the various inter­molecular inter­actions indicate that the major contributions to the crystal packing of the title mol­ecule are from H⋯H (32.8%), C⋯ H/H ⋯C (28.1%), O⋯H/H⋯O (14.0%), Br⋯H/H⋯Br (12.5%) and Cl⋯H/H⋯Cl (10.6%) contacts.

Figure 5.

Figure 5

The two-dimensional fingerprint plots for the title compound, showing all inter­actions, and those delineated into H⋯H, C⋯H/H⋯C, O⋯H/H⋯O, Br⋯H/H⋯Br and Cl⋯H/H⋯Cl contacts.

5. Database survey

A search of the Cambridge Structural Database (CSD version 2.0.4, December 2019; Groom et al., 2016) for mol­ecules containing the 4-bromo-2-chloro­phenyl moiety resulted in 15 matches. Of these, the six compounds with CSD codes EBEPUZ (Lehmler et al., 2013), EJULUT (Dumitrescu et al., 2020), ISOJUX (Reddy et al., 2016), FANFOS (Sangeeta et al., 2017) and VIDQUX (Mohan et al., 2018) have either alk­yloxy or substituted aromatic or heterocyclic rings connected fragments that are found to be in the same plane. The dihedral angle made by these planes with the 4-bromo-2-chloro­phenyl moiety are 59.0, 75.3, 88.78, 37.47, and 2.99°, respectively, whereas in the title compound, the dihedral angle between the 4-bromo-2-chloro­phenyl and (pent­yloxy)phenyl­prop-2-enoate moieties is 82.15 (2)°. The torsion angle between the ortho-substituted chlorine atom and the first atom of the planar functional group in the above compounds is between 1 and 3° while in the title compound this torsion angle is 1.2 (2)°.

6. Synthesis and crystallization

A mixture of 4-bromo-2-chloro­phenol (0.208 g, 0.001 mol) and (E)-3-[4-(pent­yloxy)phen­yl]acrylic acid (0.234 g, 0.001 mol) was suspended in anhydrous chloro­form (10 ml). To this was added N,N-di­cyclo­hexyl­carbodi­imide (0.206 g, 0.001 mol) and 4-N,N-di­methyl­amino pyridine (5 mg) and the mixture stirred overnight at room temperature. The N,N-di­cyclo­hexyl urea formed was filtered off and the filtrate diluted with chloro­form (25 ml). This solution was washed successively with 5% aqueous acetic acid solution (2 × 25 ml) and water (2 × 25 ml) and dried on sodium sulfate. The residue obtained on removal of solvent was chromatographed on silica gel using chloro­form as eluent. Removal of solvent from the eluate afforded a white material that was crystallized from a ­chloro­form–petroleum ether mixture. Yield 75%. Elemental analysis calculated: C, 56.69; H, 4.76; Br, 18.86; Cl, 8.37; O, 11.33%; found: C, 56.71; H, 4.79; Cl, 8.42%, m.p. 371–373 K.

7. Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2. H atoms were positioned geometrically (C—H = 0.93 Å) and refined as riding with Uiso(H) = 1.2Ueq(C).

Table 2. Experimental details.

Crystal data
Chemical formula C20H20BrClO3
M r 423.72
Crystal system, space group Triclinic, PInline graphic
Temperature (K) 296
a, b, c (Å) 7.5850 (7), 9.825 (1), 12.8466 (13)
α, β, γ (°) 87.176 (3), 85.069 (3), 82.934 (3)
V3) 945.85 (16)
Z 2
Radiation type Mo Kα
μ (mm−1) 2.33
Crystal size (mm) 0.32 × 0.27 × 0.24
 
Data collection
Diffractometer Bruker SMART APEXII CCD
Absorption correction Multi-scan (SADABS; Krause et al., 2015)
Tmin, Tmax 0.476, 0.570
No. of measured, independent and observed [I > 2σ(I)] reflections 14284, 4721, 4105
R int 0.035
(sin θ/λ)max−1) 0.668
 
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.027, 0.066, 1.03
No. of reflections 4721
No. of parameters 227
H-atom treatment H-atom parameters constrained
Δρmax, Δρmin (e Å−3) 0.39, −0.45

Computer programs: APEX2 and SAINT (Bruker, 2017), SHELXT (Sheldrick, 2015a), SHELXL (Sheldrick, 2015b) and Mercury (Macrae et al., 2020).

Supplementary Material

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989025003317/vu2011sup1.cif

e-81-00912-sup1.cif (431.6KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989025003317/vu2011Isup2.hkl

e-81-00912-Isup2.hkl (263.5KB, hkl)
e-81-00912-Isup3.cml (6.7KB, cml)

Supporting information file. DOI: 10.1107/S2056989025003317/vu2011Isup3.cml

CCDC reference: 2443273

Additional supporting information: crystallographic information; 3D view; checkCIF report

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

The authors acknowledge the Raman Research Institute, Bangalore, and Centre of Innovative Science, Engineering and Education (CISEE), UCS, Tumkur University, for constant support in extending the laboratory facilities. MHK thankful to BSPM’s lab for use of their computing facilities at the Department of PG Studies and Research in Physics, Tumkur University.

supplementary crystallographic information

4-Bromo-2-chlorophenyl (2E)-3-[4-(pentyloxy)phenyl]prop-2-enoate . Crystal data

C20H20BrClO3 F(000) = 432
Mr = 423.72 Prism
Triclinic, P1 Dx = 1.488 Mg m3
Hall symbol: -P 1 Melting point: 458 K
a = 7.5850 (7) Å Mo Kα radiation, λ = 0.71073 Å
b = 9.825 (1) Å Cell parameters from 4105 reflections
c = 12.8466 (13) Å θ = 2.5–29.0°
α = 87.176 (3)° µ = 2.33 mm1
β = 85.069 (3)° T = 296 K
γ = 82.934 (3)° Prism, colourless
V = 945.85 (16) Å3 0.32 × 0.27 × 0.24 mm
Z = 2

4-Bromo-2-chlorophenyl (2E)-3-[4-(pentyloxy)phenyl]prop-2-enoate . Data collection

Bruker SMART APEXII CCD diffractometer 4721 independent reflections
Radiation source: fine-focus sealed tube 4105 reflections with I > 2σ(I)
Graphite monochromator Rint = 0.035
Detector resolution: 1.02 pixels mm-1 θmax = 28.4°, θmin = 2.7°
φ and Ω scans h = −10→10
Absorption correction: multi-scan (SADABS; Krause et al., 2015) k = −13→13
Tmin = 0.476, Tmax = 0.570 l = −17→17
14284 measured reflections

4-Bromo-2-chlorophenyl (2E)-3-[4-(pentyloxy)phenyl]prop-2-enoate . Refinement

Refinement on F2 Primary atom site location: structure-invariant direct methods
Least-squares matrix: full Secondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.027 Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.066 H-atom parameters constrained
S = 1.03 w = 1/[σ2(Fo2) + (0.023P)2 + 0.4253P] where P = (Fo2 + 2Fc2)/3
4721 reflections (Δ/σ)max = 0.004
227 parameters Δρmax = 0.39 e Å3
0 restraints Δρmin = −0.45 e Å3
0.123 constraints

4-Bromo-2-chlorophenyl (2E)-3-[4-(pentyloxy)phenyl]prop-2-enoate . Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

4-Bromo-2-chlorophenyl (2E)-3-[4-(pentyloxy)phenyl]prop-2-enoate . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
Br1 0.18439 (3) 0.12617 (2) 1.03966 (2) 0.02099 (6)
Cl1 0.69315 (6) 0.12132 (7) 0.70527 (4) 0.03690 (13)
O3 0.78618 (16) 0.38029 (12) −0.06342 (9) 0.0169 (2)
O1 0.38962 (16) 0.12409 (12) 0.57472 (9) 0.0169 (2)
O2 0.3931 (2) 0.35324 (13) 0.57369 (10) 0.0260 (3)
C4 0.2485 (2) 0.12778 (16) 0.89331 (13) 0.0159 (3)
C10 0.5853 (2) 0.35279 (16) 0.24860 (12) 0.0134 (3)
C12 0.6902 (2) 0.24985 (17) 0.08324 (13) 0.0154 (3)
H12 0.716007 0.172269 0.043468 0.018*
C8 0.4799 (2) 0.23374 (17) 0.41618 (13) 0.0151 (3)
H8 0.492031 0.148155 0.386742 0.018*
C7 0.4187 (2) 0.24945 (17) 0.52630 (13) 0.0155 (3)
C11 0.6237 (2) 0.23732 (17) 0.18630 (13) 0.0155 (3)
H11 0.604072 0.151208 0.214998 0.019*
C13 0.7190 (2) 0.37875 (17) 0.03838 (12) 0.0140 (3)
C9 0.5182 (2) 0.34530 (17) 0.35835 (13) 0.0147 (3)
H9 0.499875 0.427875 0.392337 0.018*
C1 0.3422 (2) 0.12854 (16) 0.68166 (13) 0.0147 (3)
C5 0.1161 (2) 0.12990 (18) 0.82517 (14) 0.0202 (4)
H5 −0.002839 0.131054 0.850218 0.024*
C3 0.4258 (2) 0.12611 (17) 0.85862 (13) 0.0184 (3)
H3 0.512420 0.124852 0.905778 0.022*
C15 0.6154 (2) 0.48017 (17) 0.20237 (13) 0.0154 (3)
H15 0.590935 0.557698 0.242285 0.018*
C14 0.6808 (2) 0.49489 (17) 0.09858 (13) 0.0156 (3)
H14 0.699023 0.581115 0.069501 0.019*
C17 0.8891 (2) 0.49610 (18) −0.22259 (13) 0.0180 (3)
H17A 0.802673 0.458591 −0.260963 0.022*
H17B 0.997676 0.432518 −0.225787 0.022*
C18 0.9276 (2) 0.63480 (18) −0.27262 (13) 0.0186 (3)
H18A 0.819067 0.698353 −0.266778 0.022*
H18B 1.014894 0.670824 −0.234011 0.022*
C2 0.4721 (2) 0.12635 (18) 0.75163 (14) 0.0176 (3)
C16 0.8173 (2) 0.51254 (17) −0.11028 (13) 0.0159 (3)
H16A 0.902213 0.552149 −0.072138 0.019*
H16B 0.706771 0.573970 −0.107005 0.019*
C6 0.1655 (2) 0.13025 (18) 0.71820 (14) 0.0200 (4)
H6 0.078790 0.131658 0.671066 0.024*
C19 0.9971 (3) 0.6278 (2) −0.38731 (14) 0.0263 (4)
H19A 1.108096 0.567089 −0.393177 0.032*
H19B 0.911805 0.589191 −0.425798 0.032*
C20 1.0284 (3) 0.7680 (3) −0.43626 (17) 0.0380 (6)
H20A 1.074526 0.758169 −0.507796 0.057*
H20B 1.112534 0.806870 −0.398383 0.057*
H20C 0.917802 0.827400 −0.433463 0.057*

4-Bromo-2-chlorophenyl (2E)-3-[4-(pentyloxy)phenyl]prop-2-enoate . Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
Br1 0.02982 (11) 0.01924 (9) 0.01305 (9) −0.00280 (7) 0.00343 (6) −0.00147 (6)
Cl1 0.0158 (2) 0.0705 (4) 0.0242 (3) −0.0090 (2) 0.00258 (18) 0.0020 (2)
O3 0.0247 (7) 0.0142 (6) 0.0112 (6) −0.0028 (5) 0.0034 (5) −0.0005 (4)
O1 0.0242 (6) 0.0139 (6) 0.0123 (6) −0.0038 (5) 0.0028 (5) 0.0001 (4)
O2 0.0471 (9) 0.0141 (6) 0.0165 (6) −0.0068 (6) 0.0047 (6) −0.0028 (5)
C4 0.0220 (9) 0.0108 (8) 0.0141 (8) −0.0016 (6) 0.0028 (6) −0.0003 (6)
C10 0.0129 (8) 0.0148 (8) 0.0125 (8) −0.0018 (6) −0.0020 (6) 0.0005 (6)
C12 0.0177 (8) 0.0135 (8) 0.0149 (8) −0.0010 (6) −0.0008 (6) −0.0026 (6)
C8 0.0171 (8) 0.0142 (8) 0.0139 (8) −0.0019 (6) 0.0011 (6) −0.0027 (6)
C7 0.0173 (8) 0.0147 (8) 0.0142 (8) −0.0033 (6) −0.0002 (6) 0.0022 (6)
C11 0.0170 (8) 0.0128 (8) 0.0166 (8) −0.0031 (6) −0.0006 (6) 0.0012 (6)
C13 0.0145 (8) 0.0161 (8) 0.0111 (8) −0.0018 (6) −0.0006 (6) 0.0000 (6)
C9 0.0150 (8) 0.0158 (8) 0.0135 (8) −0.0015 (6) −0.0010 (6) −0.0019 (6)
C1 0.0206 (8) 0.0103 (7) 0.0125 (8) −0.0015 (6) 0.0012 (6) 0.0009 (6)
C5 0.0162 (8) 0.0247 (9) 0.0186 (9) −0.0022 (7) 0.0024 (7) 0.0028 (7)
C3 0.0190 (9) 0.0205 (9) 0.0162 (8) −0.0041 (7) −0.0024 (7) −0.0006 (6)
C15 0.0189 (8) 0.0128 (8) 0.0147 (8) −0.0025 (6) −0.0003 (6) −0.0034 (6)
C14 0.0192 (8) 0.0126 (8) 0.0147 (8) −0.0024 (6) −0.0001 (6) 0.0010 (6)
C17 0.0189 (8) 0.0211 (9) 0.0131 (8) −0.0006 (7) 0.0011 (6) −0.0013 (6)
C18 0.0171 (8) 0.0236 (9) 0.0144 (8) −0.0022 (7) 0.0002 (6) 0.0022 (6)
C2 0.0146 (8) 0.0197 (9) 0.0184 (9) −0.0043 (6) 0.0019 (6) −0.0003 (6)
C16 0.0184 (8) 0.0151 (8) 0.0138 (8) −0.0025 (6) 0.0012 (6) 0.0006 (6)
C6 0.0180 (8) 0.0253 (9) 0.0167 (9) −0.0033 (7) −0.0021 (7) 0.0021 (7)
C19 0.0214 (9) 0.0406 (12) 0.0145 (9) 0.0012 (8) 0.0016 (7) 0.0044 (8)
C20 0.0250 (11) 0.0560 (15) 0.0298 (12) −0.0034 (10) 0.0016 (9) 0.0219 (10)

4-Bromo-2-chlorophenyl (2E)-3-[4-(pentyloxy)phenyl]prop-2-enoate . Geometric parameters (Å, º)

Br1—C4 1.9009 (16) C5—C6 1.393 (2)
Cl1—C2 1.7263 (17) C5—H5 0.9300
O3—C13 1.3623 (18) C3—C2 1.389 (2)
O3—C16 1.4424 (19) C3—H3 0.9300
O1—C7 1.3858 (19) C15—C14 1.389 (2)
O1—C1 1.3914 (19) C15—H15 0.9300
O2—C7 1.200 (2) C14—H14 0.9300
C4—C3 1.378 (2) C17—C16 1.507 (2)
C4—C5 1.385 (3) C17—C18 1.528 (2)
C10—C15 1.395 (2) C17—H17A 0.9700
C10—C11 1.407 (2) C17—H17B 0.9700
C10—C9 1.459 (2) C18—C19 1.523 (2)
C12—C11 1.381 (2) C18—H18A 0.9700
C12—C13 1.399 (2) C18—H18B 0.9700
C12—H12 0.9300 C16—H16A 0.9700
C8—C9 1.341 (2) C16—H16B 0.9700
C8—C7 1.460 (2) C6—H6 0.9300
C8—H8 0.9300 C19—C20 1.523 (3)
C11—H11 0.9300 C19—H19A 0.9700
C13—C14 1.397 (2) C19—H19B 0.9700
C9—H9 0.9300 C20—H20A 0.9600
C1—C6 1.380 (2) C20—H20B 0.9600
C1—C2 1.387 (2) C20—H20C 0.9600
C13—O3—C16 116.35 (12) C15—C14—C13 119.26 (15)
C7—O1—C1 114.71 (13) C15—C14—H14 120.4
C3—C4—C5 122.21 (16) C13—C14—H14 120.4
C3—C4—Br1 118.70 (13) C16—C17—C18 110.16 (14)
C5—C4—Br1 119.09 (13) C16—C17—H17A 109.6
C15—C10—C11 117.68 (15) C18—C17—H17A 109.6
C15—C10—C9 118.90 (15) C16—C17—H17B 109.6
C11—C10—C9 123.42 (14) C18—C17—H17B 109.6
C11—C12—C13 120.30 (15) H17A—C17—H17B 108.1
C11—C12—H12 119.8 C19—C18—C17 113.57 (15)
C13—C12—H12 119.8 C19—C18—H18A 108.9
C9—C8—C7 118.63 (15) C17—C18—H18A 108.9
C9—C8—H8 120.7 C19—C18—H18B 108.9
C7—C8—H8 120.7 C17—C18—H18B 108.9
O2—C7—O1 121.15 (15) H18A—C18—H18B 107.7
O2—C7—O1 121.15 (15) C1—C2—C3 120.49 (15)
O2—C7—C8 127.83 (15) C1—C2—Cl1 119.66 (13)
O2—C7—C8 127.83 (15) C3—C2—Cl1 119.84 (14)
O1—C7—C8 111.02 (14) O3—C16—C17 109.47 (13)
C12—C11—C10 121.05 (15) O3—C16—H16A 109.8
C12—C11—H11 119.5 C17—C16—H16A 109.8
C10—C11—H11 119.5 O3—C16—H16B 109.8
O3—C13—C14 124.48 (14) C17—C16—H16B 109.8
O3—C13—C12 115.88 (14) H16A—C16—H16B 108.2
C14—C13—C12 119.64 (15) C1—C6—C5 120.49 (17)
C8—C9—C10 127.86 (16) C1—C6—H6 119.8
C8—C9—H9 116.1 C5—C6—H6 119.8
C10—C9—H9 116.1 C20—C19—C18 112.52 (18)
C6—C1—C2 119.99 (15) C20—C19—H19A 109.1
C6—C1—O1 119.64 (15) C18—C19—H19A 109.1
C2—C1—O1 120.32 (15) C20—C19—H19B 109.1
C4—C5—C6 118.32 (16) C18—C19—H19B 109.1
C4—C5—H5 120.8 H19A—C19—H19B 107.8
C6—C5—H5 120.8 C19—C20—H20A 109.5
C4—C3—C2 118.49 (16) C19—C20—H20B 109.5
C4—C3—H3 120.8 H20A—C20—H20B 109.5
C2—C3—H3 120.8 C19—C20—H20C 109.5
C14—C15—C10 122.07 (15) H20A—C20—H20C 109.5
C14—C15—H15 119.0 H20B—C20—H20C 109.5
C10—C15—H15 119.0
C1—O1—C7—O2 −4.4 (2) C5—C4—C3—C2 −0.1 (3)
C1—O1—C7—O2 −4.4 (2) Br1—C4—C3—C2 179.57 (12)
C1—O1—C7—C8 175.98 (14) C11—C10—C15—C14 0.1 (2)
C9—C8—C7—O2 1.9 (3) C9—C10—C15—C14 179.33 (16)
C9—C8—C7—O2 1.9 (3) C10—C15—C14—C13 −0.4 (3)
C9—C8—C7—O1 −178.50 (15) O3—C13—C14—C15 −178.89 (15)
C13—C12—C11—C10 −0.7 (3) C12—C13—C14—C15 0.2 (3)
C15—C10—C11—C12 0.5 (2) C16—C17—C18—C19 −178.75 (15)
C9—C10—C11—C12 −178.75 (15) C6—C1—C2—C3 −0.1 (3)
C16—O3—C13—C14 −0.5 (2) O1—C1—C2—C3 −177.82 (15)
C16—O3—C13—C12 −179.66 (14) C6—C1—C2—Cl1 178.92 (13)
C11—C12—C13—O3 179.49 (15) O1—C1—C2—Cl1 1.2 (2)
C11—C12—C13—C14 0.3 (3) C4—C3—C2—C1 0.1 (3)
C7—C8—C9—C10 178.25 (16) C4—C3—C2—Cl1 −178.89 (13)
C15—C10—C9—C8 179.46 (17) C13—O3—C16—C17 −179.32 (14)
C11—C10—C9—C8 −1.3 (3) C18—C17—C16—O3 −178.46 (14)
C7—O1—C1—C6 100.14 (18) O1—C1—C6—C5 177.77 (15)
C7—O1—C1—C2 −82.15 (19) C17—C18—C19—C20 178.03 (16)
Br1—C4—C5—C6 −179.64 (13)

4-Bromo-2-chlorophenyl (2E)-3-[4-(pentyloxy)phenyl]prop-2-enoate . Hydrogen-bond geometry (Å, º)

Cg1 and Cg2 are the centroids of the 4-bromo-2-chlorophenyl (C1–C6) and phenyl (C10–C15) rings, respectively.

D—H···A D—H H···A D···A D—H···A
C6—H6···Cl1i 0.93 2.93 3.613 (2) 131
C9—H9···O2 0.93 2.50 2.848 (2) 102
C9—H9···O2ii 0.93 2.46 3.291 (2) 149
C15—H15···O2ii 0.93 2.58 3.371 (2) 143
C11—H11···Cg1iii 0.93 2.76 3.5716 (18) 147
C16—H16B···Cg2iv 0.97 2.79 3.6687 (17) 151
C18—H18B···Cg2v 0.97 2.85 3.7194 (17) 150

Symmetry codes: (i) x−1, y, z; (ii) −x+1, −y+1, −z+1; (iii) −x+1, −y, −z+1; (iv) −x+1, −y+1, −z; (v) −x+2, −y+1, −z.

Funding Statement

Funding for this research was provided by: Vission Group of Science and Technology (award No. GRD319 to B. S. Palakshamurthy).

References

  1. Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl.34, 1555–1573.
  2. Bruker (2017). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
  3. De, P., Koumba Yoya, G., Constant, P., Bedos-Belval, F., Duran, H., Saffon, N., Daffé, M. & Baltas, M. (2011). J. Med. Chem.54, 1449–1461. [DOI] [PubMed]
  4. Dumitrescu, D., Shova, S., Man, I. C., Caira, M. R., Popa, M. M. & Dumitrascu, F. (2020). Crystals10, 1149.
  5. Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179. [DOI] [PMC free article] [PubMed]
  6. Hirshfeld, H. L. (1977). Theor. Chim. Acta44, 129–138.
  7. Hošek, J., Kos, J., Strhársky, T., Černá, L., Štarha, P., Vančo, J., Trávníček, Z., Devínsky, F. & Jampílek, J. (2019). Molecules24, 4531. [DOI] [PMC free article] [PubMed]
  8. Jung, M. E., Go, A., Yoo, D., Chae, J. H., Jeon, M. K., Lim, B. & Choi, G. (2019). Bull. Korean Chem. Soc.40, 1236–1239.
  9. Kos, J., Degotte, G., Pindjakova, D., Strharsky, T., Jankech, T., Gonec, T., Francotte, P., Frederich, M. & Jampilek, J. (2022). Molecules27, 7799–7799. [DOI] [PMC free article] [PubMed]
  10. Koti Reddy, E. C. R., Sajith, A. M. K. V. D. C. S. & Anwar, S. (2016). RSC Adv.6, 77431–77439.
  11. Krause, L., Herbst-Irmer, R., Sheldrick, G. M. & Stalke, D. (2015). J. Appl. Cryst.48, 3–10. [DOI] [PMC free article] [PubMed]
  12. Lehmler, H. J., He, X., Li, X., Duffel, M. W. & Parkin, S. (2013). Chemosphere93, 1965–1971. [DOI] [PMC free article] [PubMed]
  13. Lukáč, M., Slobodníková, L., Mrva, M., Dušeková, A., Garajová, M., Kello, M., Šebová, D., Pisárčik, M., Kojnok, M., Vrták, A., Kurin, E. & Bittner Fialová, S. (2024). Int. J. Mol. Sci.25, 1200. [DOI] [PMC free article] [PubMed]
  14. Macrae, C. F., Sovago, I., Cottrell, S. J., Galek, P. T. A., McCabe, P., Pidcock, E., Platings, M., Shields, G. P., Stevens, J. S., Towler, M. & Wood, P. A. (2020). J. Appl. Cryst.53, 226–235. [DOI] [PMC free article] [PubMed]
  15. Matta, A., Sharma, A. K., Tomar, S., Cao, P., Kumar, S., Balwani, S., Ghosh, B., Prasad, A. K., Van der Eycken, E. V., DePass, A. L., Wengel, J., Parmar, V. S., Len, C. & Singh, B. K. (2020). New J. Chem.44, 13716–13727.
  16. Mohan, B., Jana, A., Das, N., Bharti, S. & Choudhary, M. (2018). J. Mol. Struct.1171, 94–109.
  17. Pieters, L., Van Dyck, S., Gao, M., Bai, R., Hamel, E., Vlietinck, A. & Lemière, G. (1999). J. Med. Chem.42, 5475–5481. [DOI] [PubMed]
  18. Radwan, A. A., Ghorab, M. M., Alsaid, M. S. & Alanazi, F. K. (2014). Acta Pharm.64, 335–344. [DOI] [PubMed]
  19. Sangeeta, S., Ahmad, K., Noorussabah, N., Bharti, S., Mishra, M. K., Sharma, S. R. & Choudhary, M. (2017). J. Mol. Struct.1149, 183–195.
  20. Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.
  21. Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.
  22. Spackman, M. A. & Jayatilaka, D. (2009). CrystEngComm11, 19–32.
  23. Spackman, P. R., Turner, M. J., McKinnon, J. J., Wolff, S. K., Grimwood, D. J., Jayatilaka, D. & Spackman, M. A. (2021). J. Appl. Cryst.54, 1006–1011. [DOI] [PMC free article] [PubMed]
  24. Vallone, A., D’Alessandro, S., Brogi, S., Brindisi, M., Chemi, G., Alfano, G., Lamponi, S., Lee, S. G., Jez, J. M., Koolen, K. J. M., Dechering, K. J., Saponara, S., Fusi, F., Gorelli, B., Taramelli, D., Parapini, S., Caldelari, R., Campiani, G., Gemma, S. & Butini, S. (2018). Eur. J. Med. Chem.150, 698–718. [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989025003317/vu2011sup1.cif

e-81-00912-sup1.cif (431.6KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989025003317/vu2011Isup2.hkl

e-81-00912-Isup2.hkl (263.5KB, hkl)
e-81-00912-Isup3.cml (6.7KB, cml)

Supporting information file. DOI: 10.1107/S2056989025003317/vu2011Isup3.cml

CCDC reference: 2443273

Additional supporting information: crystallographic information; 3D view; checkCIF report

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES